Evidence map›Paper›PMID 41155063›Full record

ReviewBioengineering (Basel, Switzerland)2025

Artificial and Bioengineered Therapeutic Options for Corneal Endothelial Disease.

Lanxing Fu, Alfonso Vasquez Perez, Sundas Maqsood, Nick Kopsachilis, Roberta Foti, Fabiana D'Esposito, Mutali Musa, Daniele Tognetto, Caterina Gagliano, Marco Zeppieri

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lanxing FuDepartment of Ophthalmology, East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK.ORCID 0000-0003-1959-9749
Alfonso Vasquez PerezCornea and External Disease Department, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Sundas MaqsoodDepartment of Ophthalmology, Maidstone and Tunbridge Wells NHS Foundation Trust, Maidstone ME16 9QQ, UK.
Nick KopsachilisDepartment of Ophthalmology, East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK.
Roberta FotiDivision of Rheumatology, A.O.U. "Policlinico-San Marco", 95123 Catania, Italy.ORCID 0000-0002-3074-4508
Fabiana D'EspositoDepartment of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.ORCID 0000-0002-7938-876X
Mutali MusaDepartment of Optometry, University of Benin, Benin 300283, Nigeria.ORCID 0000-0001-7486-8361
Daniele TognettoDepartment of Medicine, Surgery and Health Sciences, University of Trieste, 34129 Trieste, Italy.
Caterina GaglianoDepartment of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.ORCID 0000-0001-8424-0068
Marco ZeppieriDepartment of Medicine, Surgery and Health Sciences, University of Trieste, 34129 Trieste, Italy.ORCID 0000-0003-0999-5545

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

artificial corneabiomimetic scaffoldscorneal endothelial dysfunctionendothelial keratoplastytissue engineering

Identifiers

PMID41155063
PMCPMC12561538

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.